ZNTL$1.961.51%-0.03
After Hours: 1.960.00 0.00%
Zentalis Pharmaceuticals Inc (ZNTL)
Date: 2026-10-30 16:00O: 1.99H: 1.99L: 1.86C: 1.96Vol: 1.326M
Zentalis Pharmaceuticals Inc stock is traded at $1.96, with a volume of 1,326,434. It is down -1.51% in the last 24 hours and down -29.24% over the past month. Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Previous Close:
$1.99
Open:
$1.99
24h Volume:
1,326,434
Relative Volume:
0.89
Market Cap:
$185.56M
Revenue:
$26.87M
Net Income/Loss:
-$124.13M
P/E Ratio:
-
EPS:
-$1.74
Net Cash Flow:
-$125.60M
1W Performance:
-11.31%
1M Performance:
-29.24%
6M Performance:
-51.12%
1Y Performance:
+31.99%
1-Day Range:
$1.86$1.99
1-Week Range:
$1.86$2.27
52-Week Range:
$1.21$6.95
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
Name
Zentalis Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 263-4333Address
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY, USACompare ZNTL vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZNTL Zentalis Pharmaceuticals Inc | $1.96 | $185.56M | $26.87M | -$124.13M | -$125.60M | -$1.74 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
Zentalis Pharmaceuticals Inc Stock (ZNTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zentalis Pharmaceuticals Inc Stock (ZNTL) Insider Trading
- Vultaggio VincentFeb 10 '26PAO and PFO
- Transaction
- Sale
- Cost
- $2.42
- #Shares
- 6,894
- Value ($)
- 16,699
- #Shares Total
- 146,506
- Vultaggio VincentFeb 09 '26PAO and PFO
- Transaction
- Sale
- Cost
- $2.39
- #Shares
- 3,379
- Value ($)
- 8,086
- #Shares Total
- 153,400
- Bruns IngmarFeb 09 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $2.39
- #Shares
- 335
- Value ($)
- 802
- #Shares Total
- 33,332
- EASTLAND JULIA MARIEFeb 09 '26CEO & President
- Transaction
- Sale
- Cost
- $2.39
- #Shares
- 889
- Value ($)
- 2,127
- #Shares Total
- 79,133
- Vultaggio VincentFeb 06 '26PAO and PFO
- Transaction
- Sale
- Cost
- $2.43
- #Shares
- 29,951
- Value ($)
- 72,772
- #Shares Total
- 156,779
- Bruns IngmarFeb 06 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $2.43
- #Shares
- 2,962
- Value ($)
- 7,197
- #Shares Total
- 33,667
- EASTLAND JULIA MARIEFeb 06 '26CEO & President
- Transaction
- Sale
- Cost
- $2.43
- #Shares
- 7,866
- Value ($)
- 19,112
- #Shares Total
- 80,022
- Vultaggio VincentFeb 03 '26PAO and PFO
- Transaction
- Sale
- Cost
- $2.52
- #Shares
- 556
- Value ($)
- 1,398
- #Shares Total
- 186,730
- Vultaggio VincentFeb 02 '26PAO and PFO
- Transaction
- Sale
- Cost
- $2.55
- #Shares
- 2,540
- Value ($)
- 6,477
- #Shares Total
- 187,286
- WALTERS GROUPDec 31 '2510% Owner
- Transaction
- Buy
- Cost
- $1.20
- #Shares
- 6,459,973
- Value ($)
- 7,751,968
- #Shares Total
- 13,509,973
